These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 10365591

  • 1. Increased circulating granulocyte colony-stimulating factor in acute Kawasaki disease.
    Inoue Y, Kato M, Kobayashi T, Shinohara M, Sone K, Morikawa A.
    Pediatr Int; 1999 Jun; 41(3):330-3. PubMed ID: 10365591
    [No Abstract] [Full Text] [Related]

  • 2. Studies of peripheral blood toxic neutrophils as a predictor of coronary risk in Kawasaki disease--the pathogenetic role of hematopoietic colony-stimulating factors (GM-CSF, G-CSF).
    Takeshita S, Sekine I, Fujisawa T, Yoshioka S.
    Acta Paediatr Jpn; 1990 Oct; 32(5):508-14. PubMed ID: 1704677
    [Abstract] [Full Text] [Related]

  • 3. Increased serum granulocyte colony-stimulating factor correlates with coronary artery dilatation in Kawasaki disease.
    Samada K, Igarashi H, Shiraishi H, Hatake K, Momoi MY.
    Eur J Pediatr; 2002 Oct; 161(10):538-41. PubMed ID: 12297900
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of neutrophil activation cytokines in Kawasaki disease.
    Suzuki H, Noda E, Miyawaki M, Takeuchi T, Uemura S, Koike M.
    Pediatr Int; 2001 Apr; 43(2):115-9. PubMed ID: 11285059
    [Abstract] [Full Text] [Related]

  • 5. Serum M-CSF levels in Kawasaki disease.
    Oana S, Terai M, Kohno Y.
    Br J Haematol; 1999 Nov; 107(2):462-3. PubMed ID: 10583242
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Increased macrophages, high serum M-CSF and low serum cholesterol in myelodysplasia and Kawasaki disease.
    Shetty V, Allampallam K, Raza A.
    Br J Haematol; 1999 Sep; 106(4):1068. PubMed ID: 10520017
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impaired granulocyte chemotaxis and increased circulating immune complexes in Kawasaki disease.
    Ono S, Onimaru T, Kawakami K, Hokonohara M, Miyata K.
    J Pediatr; 1985 Apr; 106(4):567-70. PubMed ID: 3981310
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Circulating soluble CD23 levels in Kawasaki disease with coronary artery lesions.
    Hirao J, Yamashita T.
    Acta Paediatr Jpn; 1997 Jun; 39(3):397-9. PubMed ID: 9241913
    [No Abstract] [Full Text] [Related]

  • 15. Increased CD11b expression on polymorphonuclear leucocytes and cytokine profiles in patients with Kawasaki disease.
    Kobayashi T, Kimura H, Okada Y, Inoue Y, Kobayashi T, Shinohara M, Morikawa A.
    Clin Exp Immunol; 2007 Apr; 148(1):112-8. PubMed ID: 17286760
    [Abstract] [Full Text] [Related]

  • 16. Kawasaki disease and oxidative metabolism.
    Lebranchu Y, Malvy D, Richard MJ, Arnaud J, Favier A, Bardos P.
    Clin Chim Acta; 1990 Mar 15; 187(3):193-8. PubMed ID: 2108832
    [Abstract] [Full Text] [Related]

  • 17. Antioxidant enzymes and lipoperoxide in blood in patients with Kawasaki disease. Comparison with the changes in acute infections.
    Uchida N, Asayama K, Dobashi K, Hayashibe H, Kato K.
    Acta Paediatr Jpn; 1990 Jun 15; 32(3):242-8. PubMed ID: 2239296
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.